Recycled Meds and New Approaches in Multiple Sclerosis
Drs. Andrew Wilner and Lawrence Steinman discuss innovative approaches to new -- and old -- drug development in multiple sclerosis. (Source: Medscape Pharmacists Podcast)
Source: Medscape Pharmacists Podcast - April 3, 2013 Category: Drugs & Pharmacology Authors: Medscape Source Type: podcasts
Sevelamer: A Phosphate Binder Friend With Benefits?
Jeffrey Berns discusses the phosphate binder sevelamer and suggests that anti-inflammatory or antioxidant effects might be an added benefit for patients with kidney disease. (Source: Medscape Pharmacists Podcast)
Source: Medscape Pharmacists Podcast - April 1, 2013 Category: Drugs & Pharmacology Authors: Medscape Source Type: podcasts
Ospemifene: A Welcome Option for Treating Vaginal Atrophy
Andrew Kaunitz covers ospemifene, a new oral nonestrogenic therapy for vulvar and vaginal atrophy, and advises physicians on its benefits and risks. (Source: Medscape Pharmacists Podcast)
Source: Medscape Pharmacists Podcast - March 20, 2013 Category: Drugs & Pharmacology Authors: Medscape Source Type: podcasts
Secondary Stroke Prevention: Are 2 Meds Better Than 1?
Dr. Hans-Christoph Diener discusses CHANCE, a trial comparing aspirin therapy with aspirin plus clopidogrel in patients with acute TIAs or minor stroke. (Source: Medscape Pharmacists Podcast)
Source: Medscape Pharmacists Podcast - March 7, 2013 Category: Drugs & Pharmacology Authors: Medscape Source Type: podcasts
Statins and Cancer Mortality: Some Comfort
Henry Black, MD, discusses positive findings suggesting that statins may reduce cancer-related mortality. (Source: Medscape Pharmacists Podcast)
Source: Medscape Pharmacists Podcast - February 25, 2013 Category: Drugs & Pharmacology Authors: Medscape Source Type: podcasts
What's New in ADA's Latest Diabetes Guidelines?
Dr. Anne Peters discusses the changes to the standards of care updated annually by the American Diabetes Association. (Source: Medscape Pharmacists Podcast)
Source: Medscape Pharmacists Podcast - February 7, 2013 Category: Drugs & Pharmacology Authors: Medscape Source Type: podcasts
Taking a Break After 100 Cycles of Bevacizumab
The last patient on the ECOG-2100 trial has stopped therapy after 100 cycles, and Dr. Kathy Miller reminds clinicians to treasure the exceptions for they can point the direction to new interventions. (Source: Medscape Pharmacists Podcast)
Source: Medscape Pharmacists Podcast - February 4, 2013 Category: Drugs & Pharmacology Authors: Medscape Source Type: podcasts
Bleeding Risk in Afib? Don't Fear Warfarin
This F1000 commentary reports on a study whose findings support the use of antithrombotic therapy in treating patients with atrial fibrillation. (Source: Medscape Pharmacists Podcast)
Source: Medscape Pharmacists Podcast - February 1, 2013 Category: Drugs & Pharmacology Authors: Medscape Source Type: podcasts
